Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.
AUTHORS
Liedtke
AJAndy J ,
Adeniji
AO Adegoke O ,
Chen
M Mo ,
Byrns
MC Michael C ,
Jin
Y Yi ,
Christianson
DW David W ,
Marnett
LJ Lawrence J ,
Penning
TM Trevor M .
Journal of medicinal chemistry. 2013 3 28; 56(6).
2429-46
- PMID: 23432095[PubMed].
- PMCID: PMC3638264.
- NIHMSID: NIHMS455938